Cromos Pharma, where the patients are

Awards & Advancement

PPD adds Bhooshi De Silva as senior vice president

Monday, April 21, 2014 10:40 AM

CRO Pharmaceutical Product Development (PPD) has added Bhooshi De Silva as senior vice president of corporate development and strategy to its executive leadership team. De Silva will focus on key strategic initiatives vital to supporting PPD’s growth and client success, including corporate development, strategy and mergers and acquisitions.

More... »

CRF Health eCOA webinar series

SMART Platforms Project names advisory committee

Friday, April 18, 2014 11:26 AM

The SMART (Substitutable Medical Apps & Reusable Technology) Platforms project at Boston Children's Hospital—which is developing technology to create an app-driven health information economy—has announced the formation of an advisory committee that will guide the project on strategy, technical approach and business development.

More... »


Ian Read becomes PhRMA board chairman; Ken Frazier, George Scangos on board

Friday, April 18, 2014 10:37 AM

Ian C. Read, chairman and CEO of Pfizer, was elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA). Read succeeds Robert J. Hugin, chairman and CEO of Celgene, as PhRMA's chairman. Also elected were Kenneth C. Frazier, chairman, president and CEO of Merck, as chairman-elect of the PhRMA board of directors, and George A. Scangos, Ph.D., CEO of Biogen Idec, as board treasurer.

More... »

Icon’s Firecrest training recognized by TransCelerate BioPharma

Monday, April 14, 2014 10:13 AM

Icon,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has announced that its Firecrest training meets TransCelerate BioPharma’s minimum criteria for International Conference on Harmonization Good Clinical Practice (ICH/GCP) training.

More... »

Jon L. Hart named CEO of med fusion

Friday, April 11, 2014 01:23 PM

med fusion, an integrated, advanced laboratory and clinical trials service organization, has appointed Jon L. Hart CEO, effective March 31. This appointment is the next step in the organization’s continued drive towards becoming the clear leader in providing lab and clinical trial support to healthcare providers and biotech/pharmaceutical companies through a patient-centric support model.

More... »

MEI Pharma adds David Urso as senior VP of Corporate Development, General Counsel

Friday, April 11, 2014 01:12 PM

MEI Pharma, an oncology company focused on the clinical development of novel therapies for cancer, has appointed David Urso senior vice president of Corporate Development and General Counsel. Urso joins MEI Pharma with more than two decades of experience in the life science industry, most recently as chief operating officer and general counsel at Tioga Pharmaceuticals, a company he co-founded in 2005 as a principal at Forward Ventures.

More... »

TrialNetworks wins Disruptive Technology and Innovator of the Year Award

Friday, April 11, 2014 11:37 AM

TrialNetworks and its Clinical Trial Optimization System won the Disruptive Innovator and Technology of the Year award from Partnerships in Clinical Trials 2014. The award honors an individual or a company with a new disruptive technology platform that has increased the efficiency and quality of clinical trials. TrialNetworks technology is used by companies including Merck, Biogen Idec, Ariad Pharmaceuticals and Infinity Pharmaceuticals to optimize clinical operations from startup through closeout.

More... »

Medidata wins award for innovative mobile app that engages patients in clinical trials

Thursday, April 3, 2014 11:38 AM

Medidata, a global provider of cloud-based solutions for clinical research in life sciences, won the Patient Engagement App Challenge (large organization category) at the 23rd Annual Partnerships in Clinical Trials Conference with a unique mobile app. The award recognizes Engage, Medidata’s app prototype, for its potential to positively transform the clinical trial experience for study participants at a time when capturing the voice of the patient is becoming increasingly important.

More... »

Icon awarded best CRO at World Vaccines Congress 2014

Thursday, April 3, 2014 11:33 AM

Icon,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has been named Best Clinical Research Organization in the Vaccine Industry Excellence (ViE) Awards.

More... »

Glythera makes appointments to support company expansion

Thursday, April 3, 2014 11:26 AM

Glythera, a biotechnology company specializing in the development of next generation bio-therapeutics, including Antibody Drug Conjugates,  through the application of its proprietary linker and stable glycan technologies PermaLink and PermaCarb, has appointed of Nigel Burns as non-executive director and Ian Evetts as commercial director. Glythera has recently validated data from their core technologies and the addition of Burns and Evetts coincides with the company’s expansion plan exploring new opportunities to provide essential support during the company’s growth plan.

More... »

CenterWatch Drugs in Clinical Trials
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs